12th Jan 2006 12:19
Sinclair Pharma PLC12 January 2006 12 January 2006 Sinclair Pharma plc Change of Broker Sinclair Pharma plc (LSE: SPH) ("Sinclair" or the "Company"), the specialtypharmaceuticals company, today announces that, with immediate effect, NomuraInternational plc is no longer acting as joint broker to the Company. Piper Jaffray Ltd. will continue in its existing role as nominated adviser andjoint broker to the Company and Bridgewell Securities Limited will continue inits role as joint broker. - Ends - Enquiries: Sinclair Pharma plc Tel: 01483 426644Michael Flynn, Chief Executive OfficerJerry Randall, Chief Financial Officer Financial Dynamics Tel: 020 7831 3113Ben Attwell Further information on Sinclair can be found on the company's website:www.sinclairpharma.com This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Sinclair Pharma